Cambridge NeuroScience was a leading neuroscience company engaged in the discovery and development of proprietary pharmaceutical products to treat a variety of severe neurological and psychiatric disorders. Warburg Pincus provided the seed capital to launch this company in 1986, and sold its position in 1997. |
||
|
|